Citation Impact
Citing Papers
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Identification of Genes Selectively Regulated by IFNs in Endothelial Cells
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Inflammation and cancer
2002 StandoutNature
Endogenous inhibitors of angiogenesis
2009
Interleukin 6 gene expression in normal and neoplastic B cells.
1989
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Temperature sensitivity of soil carbon decomposition and feedbacks to climate change
2006 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Tumor angiogenesis: past, present and the near future
2000
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.
1991
Angiogenesis in cancer and other diseases
2000 StandoutNature
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts
1989
Modulation of Interleukin‐6 Receptors in Human Cellsa
1989
Phosphorylation of secreted forms of human β2-interferon/hepatocyte stimulating factor/interleukin-6
1988
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
1995
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
2008
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Recombinant interferon‐β2 (interleukin‐6) induces myeloid differentiation
1988
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells.
1994
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
1997 StandoutNature
Chemokines and their role in tumor growth and metastasis
1998
Chemokines in tumor progression and metastasis
2005
Feedback control of gene expression
1994
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis
1988
Regional localization of the interferon-β2B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21
1988
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
CD4 + T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells
2000
Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
2004
Cancer-related inflammation
2008 StandoutNature
Programmed cell removal: a new obstacle in the road to developing cancer
2011
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
The roles of IFNγ in protection against tumor development and cancer immunoediting
2002
Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
2001
Angiogenesis as a therapeutic target
2005 StandoutNature
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor
2005
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Interleukin-6: An Overview
1990 Standout
Endogenous Inhibitors of Angiogenesis
2005
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
1988 Science
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human.
1988
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
CXCL10 Promotes Invasion-Related Properties in Human Colorectal Carcinoma Cells
2007
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.
1989
The Three Es of Cancer Immunoediting
2004 Standout
Interleukin-6 and the acute phase response
1990 Standout
Chemokines
1997 Standout
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
1991
Multiple actions of interleukin 6 within a cytokine network
1988
Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts.
1988
Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes
1990
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
1990
Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
1989
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
1998
Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.
1988
The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor
1998
Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV
1996 Science
Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.
1988
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Cancer incidence and risk factors after solid organ transplantation
2009
CXC chemokines in angiogenesis
2000
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein.
1988
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
1991 Standout
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
2001
Infection of human endothelial cells with Epstein-Barr virus.
1995
Interleukin 6: A Multifunctional Cytokine Regulating Immune Reactions and the Acute Phase Protein Response
1990
Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes.
1989 StandoutNobel
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3)
1988
Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.
1988
Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1
1997
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.
1990
The Biology of Chemokines and their Receptors
2000 Standout
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia
1989
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
2010
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes.
1988
Calreticulin: one protein, one gene, many functions
1999
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
1997
Cytokine production in the immune response to murine gammaherpesvirus 68
1996 StandoutNobel
Chemokines
1997
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
NMR structure of the calreticulin P-domain
2001 StandoutNobel
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
1996
Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
1998
Works of Sandra E. Pike being referenced
The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses
2001
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin
2002
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells
1990
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.
1984
Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
1988
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12
2000
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12
2000
A Monocyte‐derived B Cell Growth Factor Is IFN‐β2/BSF‐2/IL‐6a
1989
Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function
2002
Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes.
1988
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
1998
The role of lactic acid in autocrine B-cell growth stimulation.
1991
Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β 2 (BSF-2, IL-6)
1988 Science
Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth
1999
Interferon-inducible protein-10 identified as a mediator of tumor necrosisin vivo
1996